Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Blauvelt, Andrew
  • Mehlis, Stephanie
  • Vanaclocha, Francisco
  • Vender, Ronald
  • Zhao, Yang
  • Gilloteau, Isabelle
  • Williams, Nicole
  • Guana, Adriana
  • Tyring, Stephen

publication date

  • June 1, 2017